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Atherosclerosis is amajor cause of harm to humanhealth and a lead-
ing pathological contributor to cardiovascular morbidity and mortality
worldwide. Studies during the past decade have highlighted the impor-
tant role of the immune system in atherosclerosis (Libby, 2002;Wick et
al., 2004). Consequently, reducing the associated inﬂammation that sus-
tains the immune response has become an important target for scientif-
ic and future therapeutic investigations because lipid control alone does
not effectively prevent the progression of atherosclerosis in some pa-
tients (Hilgendorf et al., 2014). However, despite a long-known associ-
ation with atherosclerosis, B cells and immunoglobulins, important
components of the immune system, have received relatively little atten-
tion. In particular, the roles of B2 cells, which represent the vastmajority
of B cells, including follicular (FO) aswell asmarginal zone (MZ) B cells,
remained largely unexplored (Doran et al., 2012; Kyaw et al., 2010;
Lipinski et al., 2011).
In general, FO B cells, which predominantly participate in T-cell-
dependent (TD) antibody responses, might be endowed with
proatherogenic potential (Nicoletti et al., 1998). In contrast to TD FO B
cells, MZ B cells, situated peripherally to FO B cells, reside in the spleenan open access article under(Victora, 2014), which serves as the interface with the circulation, and
are located at the ﬁrst line of defense against antigens (Martin and
Kearney, 2002). MZ B cells predominantly give rise to rapid T-cell-
independent (TI) antibody responses to antigens, producing TI antibodies
(Puga et al., 2012). However, whether MZ B cells have atheroprotective
properties similar to TI B cells (e.g., B1 cells) remains unknown
(Ait-Oufella et al., 2010; Kyaw et al., 2011).
The spleen, the largest immune organ in the periphery, is the major
B2 B-cell reservoir, which harbors about 80% of FO B cells and 10% ofMZ
B cells among all splenic B cells (Tsiantoulas et al., 2014). However, it
should be noted that spleen-associated immune activity protects
against atherosclerosis (Emtiazy et al., 2013; Lammers et al., 2012;
Rezende et al., 2011), and removal of the spleen, which results in accel-
erated atherosclerosis, has been shown to deplete B1a cells from the
peritoneum, followed by a strong decrease in plasma immunoglobulin
(Ig) M titers (Kyaw et al., 2011; Wardemann et al., 2002). Moreover, it
should be emphasized that FO B cells and MZ B cells are also missing
after splenectomy. In addition, at present, there is contradictory evi-
dence concerning the role of B2 cells in atherogenesis after adoptive
transfer of splenic B2 cells (Doran et al., 2012; Kyaw et al., 2010;
Lipinski et al., 2011), and dissection of the functions of individual B2-
cell subsets (MZ versus FO) and separation of the intrinsic biological
properties of these B2 cells from effects mediated by the antibodies
they secrete during atherogenesis have yet to be performed
(Tsiantoulas et al., 2014).the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ies have suggested that commensal microbes might exert a substantial
impact on atherosclerosis (Brown and Hazen, 2015; Koren et al., 2011;
Serino et al., 2014; Tang andHazen, 2014). Remarkably, commensalmi-
crobes play an essential role in the activation of MZ B cells and B2 cell-
mediated IgG antibody production (Balázs et al., 2002; Cerutti et al.,
2012; Martin and Kearney, 2002; Puga et al., 2012; Vinuesa and
Chang, 2013; Weill et al., 2009). However, whether these effects con-
tribute to the development of atherosclerosis remains largely unex-
plored. In parallel with these ﬁndings, our previous clinical research
revealed that many autoantibodies differing from those found in chron-
ic autoimmune diseases are associatedwith atherosclerosis (Ishigami et
al., 2013). Meanwhile, previous studies have reported that human anti-
bodies cross-react with outer membrane proteins of bacteria as well as
with proteins involved in atherogenesis (Canducci et al., 2012). Howev-
er, the link between B2 cells and commensal microbes in the develop-
ment of atherosclerosis has not yet been reported.
To address the above issues, we therefore set out to characterize the
B2-cell subsets and investigated the role of commensal gut ﬂora in trig-
gering B2-cell response during atherogenesis. B2 cells were shown to
play an important immunological role in atherosclerosis and may
serve as a target for the development of therapeutic interventions.
2. Methods
2.1. Mice
ApoE KO mice (on the C57BL/6J background) were a generous gift
from Dr. Hashimoto (Yokohama City University Graduate School of
Medicine, Yokohama, Japan). C57BL/6J mice were purchased from the
Oriental Yeast (Tokyo, Japan). The number of mice per group used in
each experiment is annotated in the corresponding ﬁgure legend as n.
All mice admitted to the study survived the intended duration of the
study, and only 5-week-old male mice were used for experiments.
Until required for experiments, themicewere providedwith a standard
diet and tap water ad libitum. All of the animal studies were conducted
in accordancewith the animal care guidelines of YokohamaCityUniver-
sity Graduate School of Medicine.
2.2. Commensal Bacteria Depletion
The role of themicroﬂorawas investigated by treatingmicewith an-
tibiotics. For experiments, 5-week-old male ApoE KO mice were
assigned to the control group or the antibiotic treatment (AT) group.
Mice in the AT group were treated with a broad-spectrum antibiotic
cocktail AVNM, which contained 0.5 g/L vancomycin, 1 g/L neomycin
sulfate, 1 g/L metronidazole and 1 g/L ampicillin. The antibiotic cocktail
was provided in drinkingwater for 1week before beginning aWestern-
type diet (WD) and continued during the experimental period
(Croswell et al., 2009; Rakoff-Nahoum et al., 2004; Wang et al., 2011).
Antibiotics were purchased from Sigma orWako (Tokyo, Japan). Drink-
ing water containing antibiotics was changed every 3–4 days.
2.3. Active Induction of Atherosclerosis
Mice were provided with a WD (containing 21.22% [g/100 g] fat,
17.01% protein, 48.48% carbohydrate, and 0.15% cholesterol; Oriental
Yeast, Tokyo, Japan) and a normal chow diet (ND) respectively after
1 week of AT and were maintained on the diet for 8 weeks.
2.4. Micro-computed Tomography (CT)
Micro-CT scanning was performed to evaluate visceral and subcuta-
neous fat before sacriﬁce. Anesthetizedmicewere imaged on the in vivo
micro X-ray CT system R_mCT2 (Rigaku Co., Tokyo, Japan). The scan
conditions used were as follows: voltage, 90 kV; current, 160 μA; FOV,60 mm; scan technique, 17 s. Whole visceral and subcutaneous fat vol-
umes were traced. Quantitative measurements were performed using
Metabolic Analysis Software (Rigaku Co., Tokyo, Japan).
2.5. Quantiﬁcation of Atherosclerosis and Histologic Analysis
After 8 weeks of consuming aWD, hearts and aortas were removed,
and atherosclerotic lesions were quantiﬁed by cross-sectional analysis
of the aortic root and by en face analysis of the whole aorta. Hearts
were embedded in parafﬁn, and serial 5 μm sections were cut from
the beginning of the 3 aortic leaﬂets to the ascending aorta and then
stained with hematoxylin and eosin (H&E) stain. Afterwards, the aortas
were ﬁxed in 10% formalin, opened longitudinally, and stained for lipid
depositions with Oil Red O solution (Sigma-Aldrich, USA). Lesion areas
were calculated using the Image J program (National Institutes of
Health, USA; http://rsb.info.nih.gov/ij). For plaquemeasurements, brief-
ly, sections that captured the maximum lesion area were used to com-
pare lesion sizes between study groups. Plaque areas and the total
vessel area were determined, and the relative plaque extension was
expressed as a percentage of the total vessel area.
2.6. Histology and Immunohistochemistry
Freshly isolated spleens were weighed, imaged and then formalin-
ﬁxed, parafﬁn-embedded, and sectioned (5 μm). Spleen architecture
was evaluated after H&E staining. Numbers of germinal centers were
assessed using Image J software. Tissue samples from perivascular adi-
pose tissue (PVAT)were processed and embedded in parafﬁn according
to standard procedures. Sections of 5 μmwere stainedwithH&E stain or
CD23 antibody (Product code: ab185807, Abcam, USA). Fat cell area on
H&E-stained slides was measured using Image J software, quantifying
two different tissue sections per mouse (at least 3 mice with at least
100 fat cells in each image). In addition, CD23 antibody speciﬁc for B2
cells was used to stain B2 cells in PVAT. The percentage area of CD23
positive ﬁeld was assessed in a blinded manner using Image J software.
2.7. Preparation of Tissues for Flow Cytometry and Cell Sorting
Splenocytes and PVAT cells were harvested and processed for ﬂow
cytometry. In brief, cells were released from spleen by nicking the cap-
sule and gently rotating twomicroscope slides. Remaining erythrocytes
were removed by incubationwith a red blood cell lysing buffer (Product
No. R7757, Sigma). Meanwhile, complete PVAT cells were freed from
aortas at 4× magniﬁcation and digested by collagenase type 4
(0.5 mg/mL) (Catalog No. LS004186, Worthington Biochemicals) for
30min at 37 °C; total PVAT cells were then collected. Single-cell suspen-
sions were ﬁltered through a nylon mesh (100 μm, BD Biosciences) and
stained either with a mixture of ﬂuorochrome-conjugated anti-mouse
monoclonal antibodies CD21 (APC, CatalogNo. 561770, BD Biosciences),
CD23 (PE, Catalog No. 561773, BD Biosciences), CD45R/B220 (FITC, Cat-
alog No. 561877, BD Biosciences) or CD45 (FITC, Catalog No. 561088, BD
Biosciences), F4/80 (PE, Catalog No. 565410, BD Biosciences), CD3e
(APC, Catalog No. 557306, BD Biosciences) for 30 min on ice. Then, the
cells were resuspended in a ﬁxable 49, 6-diamino-2-phenylindole
(DAPI, Catalog No. P4864, Sigma) live/dead stain diluted with ﬂow
cytometry staining buffer (Catalog No. 00-4222-57, eBioscience).
Flow cytometric analyseswere performed on aMoFlo Astrios (Beckman
Coulter), and the results analyzed by software ver. 6.2.3. Dead
cells were excluded by FSC, SSC, and DAPI staining. Distinct B-cell
populations, T cells, and macrophages were identiﬁed upon cell
surface expression of the indicated antigens. Speciﬁcally, FO B cells
were identiﬁed as B220+CD21+/loCD23+ cells, MZ B cells were
identiﬁed as B220+CD21highCD23−/lo cells, transitional B cells
were identiﬁed as B220+CD21−CD23− cells, and B1 cells were
identiﬁed as B220lowCD23− cells. In addition, T cells were identiﬁed
as CD45+CD3e+F4/80− cells, and macrophages were identiﬁed as
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cells were sorted to higher than 99% purity from their parent gate.2.8. Real-time Polymerase-chain-reaction (RT-PCR) Analysis
Total RNA was isolated from the pooled sorted cells using RiboPure
Kit (Catalog No. AM1924, Life Technologies) or RNeasy Plus Micro Kit
(Catalog No. 74034, QIAGEN) according to the manufacturer's protocol.
1 μg of RNA was reverse-transcribed to cDNA using a High Capacity
RNA-to-cDNA Kit (Catalog No. 4387406, Applied Biosystems) according
to the manufacturer's protocol. The expression levels of major histo-
compatibility complex (MHC)-class II were analyzed by RT-PCR using
SYBR-Green (Catalog No. 4309155, Applied Biosystems) on an ABI
7500 RT-PCR machine according to the manufacturers' recommenda-
tions. The relativemRNA expression levels were determined using glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) as housekeeping
gene and the 2[−ΔΔC (T)] method. The following primers were used:
mouseMHC-class II (LeibundGut-Landmann et al., 2004): I-Aa forward,
5′-AAATTCCACCCCAGCTACCAAT-3′; I-Aa reverse, 5′-GCTGACCCAGC
AGCACAG-3′. In addition, to analyze toll-like receptor (TLR) signaling
genes, mouse TLR signaling pathway RT2 Proﬁler PCR arrays (Catalog
No. PAMM-018Z, Qiagen) were used to proﬁle the expression of 84
genes related to TLR signaling. Total RNA from pooled sorted cells was
used, and single-stranded cDNA was synthesized from 25 ng of total
RNA by using an RT2 PreAMP cDNA synthesis kit and RT2 PreAMP
Pathway Primer Mix (Catalog No. 330451; PBM-018Z, Qiagen). The
cDNAs were mixed with RT2 SYBR Green ROX qPCR Mastermix,
and RT-PCR performed in accordance with the manufacturer's instruc-
tions. Thermal cycling and ﬂuorescence detection were performed
using an ABI 7500 Sequence Detection System (Applied Biosystems).
Data were quantiﬁed using RT2 Proﬁler PCR array data analysis soft-
ware, version 3.5 (Qiagen, http://pcrdataanalysis.Sabiosciences.Com/
pcr/arrayanalysis.php?target=upload). Only Ct values b35 were in-
cluded in the calculations, and gene expression was related to the
mean expression of β2microglobulin (β2M) and GAPDH as housekeep-
ing genes, since thesewere the twomost stable of theﬁve housekeeping
genes included in the array, and the transcripts of interest were report-
ed as log2 fold changes and average expression, and the expressions of
TLRs regulated transcripts were compared between the groups as heat
maps.2.9. Quantiﬁcation of Plasma Parameters
Whole blood was harvested from mice at the time of sacriﬁce by
right ventricular puncture. Total cholesterol, low-density lipoprotein
cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and
triglyceride were determined by SRL Inc. (SRL Inc., Tokyo, Japan)
(Hashimoto et al., 2006; Hosoi et al., 2010; Irie et al., 2015) with LDL-
cholesterol Kit (Catalog No. 30173000, Sekisui Medical CO., Tokyo,
Japan), HDL-cholesterol Kit (Catalog No. 30169000, Sekisui Medical
CO., Tokyo, Japan), Cholesterol Kit (Catalog No. 460-44301, Wako,
Tokyo, Japan) and Triglyceride Kit (Catalog No. 464-44201, Wako,
Tokyo, Japan). LDL-cholesterol Kit and HDL-cholesterol Kit provided
the credible assaymethods of LDL-C and HDL-C, and have been certiﬁed
through the certiﬁcation program of the Centers for Disease Control and
Prevention (CDC) and Cholesterol Reference Method Laboratory Net-
work (CRMLN). (http://www.cdc.gov/labstandards/crmln_clinical.html.
and http://www.sekisuimedical.jp/business/diagnostics/biochemistry/
ldl/attention.html). Immunoglobulin measurement: Total serum IgG
and IgG3 were measured in diluted serum with the Mouse IgG ELISA
Kit (Bethyl Laboratories, E99-131) and Mouse IgG3 ELISA Kit (Bethyl
Laboratories, E99-111) according to the manufacturer's instructions.
Data were expressed as microgram per milliliter, based on the standard
curves of isotype standards.2.10. Depletion of B2 Cells by Antibody Treatment
To determine the possible involvement of commensal microbe-spe-
ciﬁc activation of B2 cell subsets in atherogenesis development, we ad-
ministered a neutralizing anti-CD23 antibody (Puriﬁed Rat Anti-Mouse
CD23, BD Pharmingen™, B3B4) to ablate B2 cells or saline (to serve as a
control) 50 μg i.p. (0.5 μg/μL; 100 μL) 1 week prior to startingWD treat-
ment and then 50 μg i.p. each week during the induction of atheroscle-
rosis (Coyle et al., 1996; Dasic et al., 1999).
2.11. Statistical Analysis
Statistical analyses were performed with the SPSS 22 software pro-
grams. Differences between groups were considered to be statistically
signiﬁcant when p b 0.05 using the appropriate tests. We used one-
way ANOVA tests followed by Tukey post hoc tests when values were
normally distributed or nonparametric Kruskal–Wallis tests when
values were not normally distributed, as speciﬁed in the ﬁgure legends.
3. Results
3.1. Gut Commensal Microﬂora Promote the Development of
Atherosclerosis
To assess the impact of gut commensal microﬂora on atherosclero-
sis, AT was used to eliminate the gut commensal microﬂora. Although
we did not perform bacterial culture of feces or RT-PCR ampliﬁcation
of 16S rRNA gene sequences to quantitatively analyze the total biota,
the results of previous studies indicate that a broad-spectrum antibiotic
cocktail (AVNM) has sufﬁcient activity to deplete all detectable com-
mensal bacteria (Rakoff-Nahoum et al., 2004; Wang et al., 2011), and
macroscopic examination of the GI tract revealed characteristic second-
ary ﬁndings associated with the depletion of gut commensal bacteria,
such as marked swelling of the cecum ascribed to the accumulation of
undigested mucus (Barthel et al., 2003; Croswell et al., 2009). These
ﬁndings indicated a reduction in the levels of colonizing bacteria (not
shown). The bodyweights in theWD group andND groupwith orwith-
out AT were monitored weekly, and the results are shown in Fig. 1A.
Body weight differed signiﬁcantly between the WD group and ND
group (p b 0.05). However, there was no obvious difference in body
weight between the WD-fed mice and the age-matched WD-AT mice.
This ﬁnding indicated that elimination of the intestinal microbiota by
AT had no impact onWD-inducedweight gain. Intriguingly, AT resulted
in increased visceral and subcutaneous fat duringWD feeding, whereas
micro-CT analysis at the end of the 8-week diet study showed no chang-
es in visceral or subcutaneous fat in ApoE KOmice given a WD as com-
pared with those given a ND. However, after AT, signiﬁcant increases in
visceral fat (p b 0.05) and subcutaneous fat (p b 0.01) were seen only in
mice given a WD (Fig. 1B–D). The increased visceral and subcutaneous
fat gain observed inWD-ATmice prompted us to test whether this phe-
nomenon was accompanied by metabolic alterations. Indeed, we de-
tected dyslipidemia in the WD-AT mice. In parallel with the CT results,
the serum lipid levels increased signiﬁcantly in the WD-AT mice, and
the serum total cholesterol and LDL-C levels were signiﬁcantly higher
in the WD-AT mice than in the WD-fed mice (p b 0.05) (Fig. 1E–H). Al-
though the changes in the plasma cholesterol levels were obvious, ath-
erosclerotic lesion size, which was determined by oil red O staining of
whole aortas after 8 weeks of a WD, surprisingly indicated that AT sig-
niﬁcantly decreased en face atherosclerotic lesion size associated with
a WD (p b 0.001) (Fig. 1I). Histological examination of the aortic roots
conﬁrmed a similar decrease in atherosclerotic lesion size (p b 0.05)
(Fig. 1J), as well as in and macrophage and T cell-rich areas (data not
shown). To assess whether these phenotypes were speciﬁc to ApoE
KO mice, the same analyses were performed in normal C57BL/6J mice,
and as expected similar results were obtained (Supplementary Fig.
S1). Analysis of the relation between plaque size and total cholesterol
Fig. 1. Antibiotic treatment mice are resistant to diet-induced atherosclerosis. Mice given a Western diet or normal chow diet with or without antibiotic treatment for 8 weeks. (A) Body
weights. AT: antibiotic treatment; WD: Western diet; ND: normal chow diet. Data pooled from three independent experiments (means ± SEM. n = 7 for each group). (B–D)
Representative micro-CT images of fat (B) and quantiﬁcation of total percent of visceral fat volume (C) and subcutaneous fat volume (D) are shown. Data are representative of three
independent experiments (means ± SEM. n = 7 for each group) *p b 0.05, **p b 0.01, ***p b 0.001 according to the post hoc ANOVA statistical analysis. (E–H) Serum levels of total
cholesterol (E), LDL (F) and HDL cholesterol (G), and triglyceride (H) were assessed. LDL: low-density lipoprotein; HDL: high-density lipoprotein. Results are presented as means ±
SEM. n = 7 per group, *p b 0.05, **p b 0.001. (I and J) Aortic lesion size was assessed by oil red O (I) and HE staining (J). Representative images and quantiﬁcation of oil red O staining
of aortas prepared en face are shown in I (% of aortic surface area, n = 12 for each group). Representative images and quantiﬁcation of maximum lesion area within the aortic root
sections as determined by HE staining are shown in J (n = 12 for each group). Scale bars represent 100 μm. Data pooled from three independent experiments. *p b 0.05, **p= 0.001,
comparing WD vs. the other groups by ANOVA.
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cates that proatherogenic effects are related to gut commensalmicroﬂo-
ra and do not solely depend on hypercholesterolemia. Collectively,
these data suggest that gut commensalmicroﬂora also can promote ath-
erosclerosis development through lipid metabolism-independent
mechanism.
3.2. AT Reduced Atherosclerosis by Abolishing the WD-induced Increase in
FO B Cells
Beside the spleen, B cells are also known to reside in the adventitial
layer of vessels (Gräbner et al., 2009; Hamze et al., 2013). On the other
hand, the role of gutmicrobes in regulating the immune system through
metabolism-independent pathways has been identiﬁed (Brown and
Hazen, 2015; Drosos et al., 2015). Therefore, to test the hypothesis
that the impact of intestinal microbiota on atherosclerosis is via activa-
tion of B2 cells, we initially analyzed B2-cell populations in spleen and
PVAT.
In healthy individuals, adipose tissue expansion occurs by
enlargement of the fat pad mass through enhanced recruitment of
adipocyte precursor cells that differentiate into small adipocytes. Incontrast, pathological expansion of adipose tissue is characterized
by rapid growth of the fat pad through enlargement of existing fat
cells. Such pathological expansion is associated with chronic inﬂam-
mation (Sun et al., 2011). Therefore, the observed metabolic syn-
drome in WD-fed and WD-AT mice indicated that pathological
adipose tissue expansion might occur in these mice. As expected, ad-
ipocytes in the PVAT ofWD-fedmice were larger, less organized, and
more loosely packed as compared with adipocytes in the control
group (p b 0.001; Fig. 2A–B). However, as shown in Fig. 2A–B, typical
features of adipocytes in the PVAT of WD-AT mice did not signiﬁ-
cantly differ from those in ND-fed mice. Moreover, we examined
the effect of the elimination of gut commensal microﬂora on the ac-
cumulation of B2 cells in the PVAT of WD-fed mice. Consistent with
the above ﬁnding, WD-fed mice showed a signiﬁcant increase in
the accumulation of CD23-positive cells as assessed by immunohis-
tochemical analysis (p b 0.001; Fig. 2B–C). Conversely, the numbers
of CD23-positive cells were equivalent in the WD-AT and control
group (Fig. 2B–C), suggesting that pronounced B2 cell inﬁltration
was augmented in the PVAT of WD-fed mice and completely
abolished along with the depletion of all detectable commensal bac-
teria. These ﬁndings support the notion that accumulating B2 cells
Fig. 2. Antibiotic treatment controls atherosclerosis by blocking B2 cells expansion. At the end of 8 weeks of a Western diet (WD) or normal chow diet (ND), the effects of antibiotic
treatment (AT) on the typical features of PVAT expansion and accumulation of CD23 positive cells are shown in A–C. (A) Mean adipocyte diameter was quantiﬁed in PVAT sections.
The surface area of at least 250 adipocytes per image was counted, and a total of seven images per PVAT were analyzed with ImageJ software. Data represent means ± SEM from n =
7 experiments. *p b 0.001 for 1-way ANOVA with Tukey corrections. (B and C) Representative images (B) and quantiﬁcation of CD23-positive staining in PVAT sections (C). Scale bars
represent 50 μm. Values are presented as means ± SEM. *p b 0.001, comparing WD vs. the other groups by ANOVA. (D and E) Flow cytometry analysis of (D) follicular (FO) B cells of
PVAT, (E) FO B cells and marginal zone (MZ) B cells in spleen, respectively (n = 6 mice per group). Data from 14 mice pooled from 3 independent experiments. Cell counts are
presented as means ± SEM. *p b 0.01, **p b 0.001. (F and G) Concentrations of total IgG (F), IgG3 (G) were assessed by ELISA. Values are presented as means ± SEM. n = 6 per group
from 3 independent experiments, *p b 0.05, **p b 0.01, ***p b 0.001 by Tukey post-hoc test. (H) RNA expression of MHC class II analyzed in puriﬁed, cell-sorted B220+CD21+/loCD23+
(FO B cells), B220+CD21highCD23−/lo (MZ B cells) in spleen digest from WD and WD-AT by real-time polymerase chain reaction and normalized to GAPDH. Results are presented as
means ± SEM. fold change of 2△Ct, *p b 0.05, n = 7 per group.
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testinal microbiota.
To further conﬁrm the above ﬁndings, we studied the B2 cells of
PVAT by ﬂow cytometry. Representative ﬂow cytometry plots along
with our gating strategy to differentiate these subsets are depicted in
Fig. 2D. In the PVAT, the proportion of activated FO B cells dramatically
increased in the mice given a WD as compared with those given a ND
(p b 0.001). However, aftermicrobiota depletion byAT, theWD-induced
increase in FO B cells was abolished (p b 0.001) which was consistent
with the above ﬁnding. Concomitantly, we also investigated B2 cells in
the spleen, themajor B cell reservoir. Although there was no signiﬁcant
difference in spleen weight (Supplementary Fig. S2A), andWD-feeding
and AT did notmodify the overall percentage of FO B cells in spleen (Fig.
2E) and was not associated with changes in splenic architecture indica-
tive of FO B cell activation on histological staining (Supplementary Fig.
S2B–C), the proportion of MZ B cells was signiﬁcantly decreased in the
mice given a WD after AT (p b 0.01; Fig. 2E). Furthermore, we also
conﬁrmed the above results in normal C57BL/6J mice (SupplementaryFig. S3). Remarkably, thenumbers of activated FO B cellswere expanded
in the PVAT of WD-fed mice, whereas AVNM-mediated microbiota de-
pletion led to a signiﬁcant reduction in FO B2 cells, and the expansion
was completely abrogated in C57BL/6J mice (Supplementary Fig. S3).
In addition, as the primary function of activated B cells is to produce an-
tibodies, we also investigated whether AT altered circulating IgG titers
(Fig. 2F–G). Although the increased number of FO B cells was not asso-
ciated with increased total IgG titers in the serum of the mice given a
WD as compared with the mice given a ND, after AT, the total IgG titers
in the serum sharply decreased, followed by reductions in FO B cells and
MZ B cells (p b 0.01; Fig. 2F). Moreover, analyses of IgG3, which is a spe-
ciﬁc subclass of IgG andmainly produced byMZ B cells via a TI pathway
under preimmune conditions or after immunization (Guinamard et al.,
2000; Panda et al., 2013), revealed that WD-AT mice displayed
decreased serum levels of IgG3 as compared with WD-fed mice
(p b 0.05; Fig. 2G). Moreover, there was also a trend toward increased
serum levels of IgG3 in WD-fed mice relative to the ND-fed mice, al-
though the difference did not reach statistical signiﬁcance. We further
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can mediate antigen presentation and represent another important
function of activated B cells. Although there was no difference in spleen
FO B2 cells between the WD group and WD-AT group on ﬂowFig. 3.Distinct gene expression proﬁles associatedwith TLR signaling pathway in B2 cells follow
MZ B cells from spleen were analyzed by mouse toll-like receptor signaling pathway RT2 Pro
compared among the indicated FO B2 cell groups (A) and indicated MZ B2 cell groups (B), res
green, min (magnitude of gene expression).cytometric analysis (Fig. 2E), as shown in Fig. 2H, AT signiﬁcantly de-
creased MHC-class II expression in spleen FO B2 cells of WD-fed mice.
Therefore, these data suggest that intestinalmicrobiota-induced athero-
sclerosis is characterized by B2-cell activation.ingWD andAT.Messenger RNApreparations of sorted FO B cells fromPVAT and spleen and
ﬁler PCR arrays. Gene expression reportedly associated with TLR signaling pathway was
pectively. Results are displayed as heat maps. Red, max (magnitude of gene expression);
Table 2
Up-down regulation in the expression of genes relevant to TLRs signaling
pathway in MZ B cells in the WD group versus WD+ AT group.
Gene Fold regulation in MZ B cells
(compared with WD group)
Chuk 3.8971
Fos 2.6863
Hspa1a −2.3842
Ikbkb 2.6361
Irf1 2.0659
Mapk8 2.6917
Mapk8ip3 6.4522
Mapk9 3.1227
Tlr5 −2.4133
Tollip 2.1339
Tradd 3.121
Traf6 3.3725
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and Inﬂammatory Gene Expression during Atherogenesis
B cells exhibit variations in TLR expression patterns, which may di-
rectly transduce microbiota-derived signals. Alternatively, microbiota-
derived signals via TLRs can modify B cell responses such as antibody
production, antigen presentation, and cytokine secretion (Nickerson et
al., 2010; Pasare andMedzhitov, 2005; Rawlings et al., 2012). The afore-
mentioned results indicate that antibody responses are diminished via
elimination of intestinal microbiota in WD-fed mice. Therefore, to fur-
ther characterize these B2 cells and decipher whether B2-cell TLR sig-
naling contributes to the microbiota-induced atherosclerosis observed
inWD-fed mice, we isolated B2 cells from spleen and PVAT and quanti-
ﬁed gene expression of TLR signaling. As expected, comparisons of the
WD andWD-AT groups revealed a substantial different in gene expres-
sion proﬁles (Fig. 3A and Tables 1–2). Although TLR expression was un-
affected (Supplementary Table S1), we found that the gene expression
levels of proinﬂammatory cytokines were indeed elevated in FO B2
cells from PVAT of WD-fed mice. As the most striking difference, the
transcription of CD14, which encodes the molecule surface antigen
CD14, a molecule required for B-cell function, was signiﬁcantly up-reg-
ulated in FO B cells of PVAT. Moreover, previous studies revealed that
CD14 is a component of the innate immune system and acts as a co-re-
ceptor alongwith TLR 2 and TLR 4 for the detection of bacterial lipopoly-
saccharide (LPS) (Heumann et al., 2001; Tasaka et al., 2003). In addition,
the genes encoding inﬂammation-activated related molecules, includ-
ing chemokine ligand 2 (Ccl2), heat shock 70 kDa protein 1a (Hspa1a),
interleukin 1 beta (IL1β), interleukin 1 receptor, type 1 (IIl1r1), prosta-
glandin-endoperoxide synthase 2 (Ptgs2), and tumor necrosis factor re-
ceptor superfamily member 1a (Tnfrsf1a), were also up-regulated. In
contrast to FO B2 cells from the spleen of WD-fed mice, the expressions
of CCAAT/enhancer binding protein, beta (Cebpb) and NF-kappa-B in-
hibitor beta (Nfkbib), which are negative regulators of TLR signaling,
were induced in WD-AT mice, whereas the expressions of the inﬂam-
mation-activated related genes Hspa1a and Ptgs2were dramatically re-
duced (Table 1). These ﬁndings strongly suggest that the observed
changes resulted from the elimination of the intestinal microbiota,
which promotes atherosclerosis via activation of B2-cell TLR signaling
pathway. B2-cell TLR signaling thusmediatesmicrobiota-driven athero-
sclerosis. Taken together, these ﬁndings support a speciﬁc role of TLR
signaling in B2 cells during microbiota-driven atherosclerosis.
3.4. B2-cell Deﬁciency Attenuates Microbiota–induced Atherosclerosis
Because intestinal microbiota depletion may inﬂuence the develop-
ment of atherosclerosis by reducing thenumber of activated B2 cells, we
further investigated whether B2-cell deﬁciency might afford protection
against microbiota-induced atherosclerosis. A cohort of WD-fed miceTable 1
Relative fold changes in the expression of genes relevant to TLR signaling pathway in FO B
cells.
Gene Fold regulation (compared with spleen FO B cells of WD
group)
FO B cells of spleen
(WD-AT group)
FO B cells of PVAT
(WD group)
Ccl2 −1.1481 17.8381
Cd14 1.993 7.189
Cebpb 3.2331 1.1982
Fos 1.726 −3.5108
Hspa1a −5.1166 9.3761
Il1b −1.0307 3.3433
Il1r1 1.2616 3.5637
Jun 1.2743 −2.16
Nfkbib 2.8025 1.5068
Ptgs2 −2.3499 3.9493
Tnfrsf1a 1.5827 2.7597was pretreated with a B2-cell–depleting agent, anti-mouse CD23 anti-
body. Intraperitoneal injections of anti-CD23 antibody were started
1 week before the development of atherosclerosis. The control group
for these experiments comprised mice pretreated with saline. As ex-
pected, mice that received the mouse-speciﬁc CD23 antibody had far
fewer B2 cells in their spleens and PVAT than did mice treated with sa-
line (Fig. 4A–B). There were no changes in other cell populations (Sup-
plementary Fig. S4). Furthermore, we found that WD-fed mice treated
with anti-CD23 antibody gained weight in association with increased
visceral and subcutaneous fat and serum lipid levels, similar to the
WD-fed controls (Fig. 4C–I). However, after 8 weeks of WD, we com-
pared plaque in WD-fed mice versus WD-fed plus anti-CD23 anti-
body-treated mice. WD-fed plus anti-CD23 antibody-treated mice
exhibited a marked reduction in plaque formation as compared with
that in WD-fed mice (Fig. 4J–K). At the same time, serum IgG and
IgG3 levels were found to be elevated only in WD-fed mice not treated
with antibody (Fig. 4L–M). These results conﬁrmed that potential trig-
gering of atherosclerosis by microbiota requires initial help from B2
cells. Altogether, these data indicate that microbiota aggravates athero-
sclerosis by stimulating activated B2-cell production and shifting the
host response toward TH1-associated immunity.
4. Discussion
Studies presented here provide evidence supporting a critical role of
commensal microbe-speciﬁc activation of B2 cell subsets in the develop-
ment of atherogenesis through lipid metabolism-independent mecha-
nism. First, we showed that WD-dependent atherosclerosis in mice is
associated with B2 cell activation in PVAT, along with increases in total
IgG and IgG3 levels in serum. However, microbiota depletion with
broad-spectrum antibiotics (AVNM) resulted in signiﬁcant and selective
reductions in the numbers of FO B2 cells in PVAT and MZ B2 cells in
spleen. Furthermore, we found that activation of B2 cell TLR signaling-
related genes was associated with an increased capacity of B2 cells to
bind the intestinal microbiota. Finally, as proof of concept that B2 cells
can be targeted therapeutically to reduce atherosclerosis, we demon-
strated that an anti-B2-cell antibody (CD23) effectively prevented com-
mensal microbe-derived atherosclerosis in response to hyperlipidemia.
The intriguing relationship between commensal microbes and ath-
erosclerosis has received increasing attention over the past few years.
However, the speciﬁcmechanismswhereby commensalmicrobes regu-
late the development of atherosclerosis are just beginning to be eluci-
dated (Brown and Hazen, 2015; Koren et al., 2011; Serino et al., 2014;
Tang and Hazen, 2014). Recently, Spence et al. found that a number of
metabolites from proteins/amino acids in the diet, including p-cresyl
sulfate, indoxyl sulfate, and others (Spence et al., 2016), might contrib-
ute to development of cardiovascular disease (CVD). Previous studies
have identiﬁed the pathway linking dietary lipid intake, intestinal mi-
croﬂora, and atherosclerosis. These studies indicated that increasing
Fig. 4. Pharmacological depletion of B2 cells protects mice from atherosclerosis. (A and B) Representative ﬂow cytometric plots of B2 cell numbers in the PVAT (A) and spleens (B) of mice
treated with a mouse speciﬁc CD23 antibody or saline (n= 6 per group). (C) Body weights measured at the end of 8 weeks of a Western diet inmice treated with a mouse speciﬁc CD23
antibody or saline. Values are presented asmeans±SEM fromn=6 experiments. (D and E)Micro-CT of total percent of visceral fat volume (D) and subcutaneous fat volume (E). Data are
representative as means ± SEM. n = 6 for each group. (F–I) Serum levels of total cholesterol (F), LDL (G) and HDL (H) and triglyceride (I) were assessed. LDL: low-density lipoprotein;
HDL: high-density lipoprotein. Results are presented as means ± SEM. n = 6 per group. (J and K) Effect of an anti-mouse CD23 antibody on plaque formation is shown in J–K. (J)
Representative images and quantiﬁcation of oil red O staining of aortas prepared en face. (K) Representative HE staining of aortic root sections and quantiﬁcation of maximum lesion
area. Group data (means ± SEM) from n = 6 experiments. Scale bar, 100 μm. *p b 0.05, **p b 0.001 for 1-way ANOVA with Tukey's corrections. (L and M) Concentrations of total IgG
(L) and IgG3 (M) in serum from mice treated with a mouse speciﬁc CD23 antibody or saline. Values are presented as means ± SEM from n = 6 experiments. *p b 0.05, **p b 0.01 for
1-way ANOVA with Tukey's corrections.
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tinal microbiome, such as the trimethylamine-N-oxide from phosphati-
dylcholine and other forms of choline and carnitine (Koeth et al.,
2013; Tang et al., 2013; Wang et al., 2011), was associated with
CVD. The pathway of the metabolism of these toxic metabolic prod-
ucts of the intestinal microbiome represents a unique additionalnutritional contribution to the pathogenesis of CVD. In fact, numer-
ous studies have shown that commensal microbe-derived metabo-
lites can act as hormones modulating CVD risk (Brown and Hazen,
2015). Metabolism-independent pathways, in particular the role of
the immune system in commensal microbe-derived atherosclerosis,
remain largely unexplored.
245L. Chen et al. / EBioMedicine 13 (2016) 237–247Our study showed that serum lipid levels were signiﬁcantly in-
creased in WD-fed mice regardless of AT or not, which is in line with
previous observations (Fu et al., 2015; Le Chatelier et al., 2013;
Velagapudi et al., 2010). However, it remains unclear how the gut mi-
crobiota affects serum lipid metabolism and systemic lipid metabolism
in adipose tissue. It is thought that hyperlipidemia (especially LDL-C)
generates an adaptive immune response mediated by autoantibody
that is produced by activated B cells and then induces atherosclerosis
(Hermansson et al., 2010; Hilgendorf et al., 2014). However, in the pres-
ent study, there was no correlation between lipid levels and atheroscle-
rosis development. Therefore, we determined whether B2-cell
activation is mediated by microbiota rather than by hyperlipidemia in
atherosclerosis. Here, we conﬁrmed, by eliminating the intestinal mi-
crobiota and depleting B2 cells in theWD-fedmice, that hyperlipidemia
did not directly potentiate atherosclerosis by altering B2-cell activation.
Our results provide novel evidence that B2 cells are causally related to
microbiota-induced atherosclerosis. Our ﬁndings also indicate that
proatherogenic effects do not solely depend on hypercholesterolemia-
induced immune response. Clinically, these ﬁndings may explain why
only control of lipids is not effective preventive therapy in somepatients
with atherosclerosis.
B cells play a complex role in the development of atherosclerosis via
antibody production. In particular, the role of B2 cells in atherosclerosis
is highly debatable (Kyaw et al., 2010; Tsiantoulas et al., 2014). As such,
understanding the impact of B2 cells on atherosclerosis and elucidating
factors that regulate their activity are important. In the present study,
our observed differences in FO B cells of PVAT between the WD group
and WD-AT group suggest that FO B cells are missing from the PVAT
in the WD-AT group, potentially due to commensal microbe deletion
by broad-spectrum antibiotics. However, it remains controversial
whether commensal microbes directly induce B2-cell activation during
the development of atherosclerosis and whether activated B2 cells play
a critical role in this process. Thus, future studies are needed to deter-
mine whether B2 cells are essential for commensal microbe-derived
atherogenesis and to elucidate potential atherogenic pathways. It is
known that one of the early consequences of B2 cell activation is the
up-regulation of costimulatory molecules, such as MHC class II mole-
cules, which can serve to enhance B cell interactions and present anti-
gen (Jiang et al., 2013; Jin et al., 2014). Another major outcome of B2-
cell activation is the production of large amounts of speciﬁc antibodies
(Shapiro-Shelef and Calame, 2005). The results of our study apparently
showed that a greater proportion of B2 cells expressedMHCclass IImol-
ecules in the spleen ofWD-fedmice.We also detected elevated levels of
IgG. In particular, the IgG subclass IgG3 displayed the highest activity in
serum, whereas AT signiﬁcantly reduced the expression of MHC class II
molecules and the levels of IgG and IgG3. These results support the con-
cept that microbiota-induced atherosclerosis is associated with B2-cell
activation.
It is thought that B cells can be activated by stimuli such as danger-
associated and pathogen-associatedmolecular patterns via TI processes.
Activated B cells then modify responses such as antigen presentation
and antibody production (Vinuesa and Chang, 2013). In general, as
one of the pathogen-associated molecular patterns, commensal mi-
crobes or commensal microbe-derived LPS or peptidoglycan can be
selectively recognized by the host's innate immune TLRs (Kawai
and Akira, 2010). In fact, many studies have demonstrated that
TLRs are contributors to atherosclerosis development (Edfeldt et
al., 2002). As mentioned above, B cells are known to express TLRs
(Nickerson et al., 2010; Pasare and Medzhitov, 2005). However, the
functions of TLRs are traditionally linked to their effect on macro-
phages or dendritic cells, and the role of TLR signal pathway in B2
cells during the development of atherosclerosis remains to be fully
elucidated. In our study, the up-down regulation of several TLR path-
way-related genes that encode inﬂammation-related molecules in
B2 cells suggests that B2-cell activation is driven by the microbiota
via B2-cell TLR signaling pathway during atherosclerosis. Takentogether, these results intriguingly suggest that under hyperlipidemic
conditions, signals driven by the microbiota via TLR signaling pathway
cause B2 cells to become functionally active and then generate active
antibodies, cytokines, and chemokines, thereby contributing to the
development of atherosclerosis.
Although B2 cells are not the only cell type thatmediates atherogen-
esis, the results of the present study collectively demonstrate that B2
cells play an essential role in promoting commensal microbe-derived
atherosclerosis, and consequently, the entire cascade leading to further
acceleration of disease development in ApoE KO mice. We therefore
suggest that future therapies could operate by shifting the homeostatic
balance of B2 cells or their activation status. Actually, in the present
study, although AT normalized the overly active B2 cell population in
atherosclerosis, the extent to which this treatment affects the immune
system or other immunocytes is open to future investigations. There-
fore, in the present study, we then further tested deﬁnitively whether
B2-directed therapies, such as ablation of B2 cells with a B2 cell-deplet-
ing, anti-mouse CD23 antibody, could serve as a therapeutic target in
atherosclerosis. CD23 is the low-afﬁnity IgE Fc receptor expressed on
mature resting conventional B2 cells, but not on B1 cells or T cells.
CD23 is a B2-cell-speciﬁc antigen, and it is now known that the func-
tions of CD23 include a role in B2 cell growth, antigen presentation, ger-
minal center B2 cell survival, prothymocyte maturation, myeloid
precursor proliferation, and, possibly, a role in protecting cells from ox-
idative stress (Stief et al., 1994). Moreover, recent studies also have
demonstrated that CD23 in B2 cells binding to macrophages leads to a
pro-inﬂammatory pattern of activation and cytokine secretion (Dasic
et al., 1999; Lecoanet-Henchoz et al., 1995). In the present study, anti-
CD23 antibody-treated mice had markedly reduced numbers of B2
cells but an otherwise relatively intact immune system. Conﬁrming
this, we showed that under physiological (i.e., ND) conditions, anti-
CD23 antibody treated-mice were virtually devoid of B2 cells in spleen.
In contrast, the numbers of T cells and macrophages were largely unaf-
fected in spleen. Therefore, these ﬁndings suggest that pharmacological
depletion of B2 cells within the WD-fed mouse results in reduced
susceptibility to atherosclerosis mediated by the commensal microbe-
speciﬁc activation of B2 cells. Further studies of B2-cell ablation in nor-
mal human subjects and in patients are required to establish the trans-
lational value of our ﬁndings, which could potentially lead to important
therapeutic approaches. In addition, as mentioned above, in future
studies using our model it would be of interest to evaluate the effects
of increasing the dietary intake of precursors of toxic metabolic prod-
ucts of the intestinalmicrobiomeon thedevelopment of atherosclerosis.
Such effects might act independently of, or perhaps bemediated by, the
B2-cell effects on atherosclerosis that we have described.
In summary, our results provide evidence for a hitherto unrecog-
nized pathway of immune activation in atherosclerosis, which driven
by B2 cell that sense microbiota via TLRs pathway.
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